1
2
Mar. 20, 2023 —In 2020, bulevirtide (BLV) was conditionally approved for treating chronic hepatitis delta (CHD), an inflammation of the liver caused by hepatitis D virus (HDV). Now real-world studies of patients ...
Mar. 29, 2022 —Infections with hepatitis C and E are so common that, going only by statistics, many people should be infected with both viruses at the same time. However, only very few such cases have been ...
Oct. 4, 2022 —The hepatitis B virus (HBV) is responsible for one of the most serious and common infectious diseases. Transmitted through biological fluids, it attacks the liver cells. The chronic form of the ...
Feb. 18, 2022 —Researchers report that patients with chronic hepatitis C who are treated with direct-acting antiviral medicines are less likely to be hospitalized or seek emergency care for liver and non-liver ...
July 14, 2022 —Researchers have created a liquid biopsy test, which uses two circulating proteins, to test for major liver diseases. The test was found to be highly accurate, sensitive, and specific for both NASH ...
Mar. 2, 2022 —As of today, there is no vaccine against hepatitis C. To improve the search for it, researchers are looking for a so-called surrogate model: an animal that can also suffer from viral hepatitis and ...
Nov. 3, 2022 —Even after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in advanced liver disease. Researchers have shown that the ...
Oct. 5, 2020 —The 2020 Nobel Prize in Physiology or Medicine is being awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice for the discovery of Hepatitis C ...
Apr. 20, 2022 —New research has identified a crucial link between arthritis and the risk of serious liver disease in people with ...
Feb. 4, 2021 —由于d 260 million people, more than three percent of the global population, are chronically infected with the hepatitis B virus (HBV); in the long term, this often leads to complications such as ...